Additionally, Trohatou et al. verified that miR-26a mediates adipogenesis of amniotic fluid mesenchymal stem cells by interfering with CCNE1 [75], and Xin Zhang et al. demonstrated that miR-26a/b can regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer [33]. The gene discussed is CDC6; the disease is lung carcinoma.